Back to Search

PTIX

Performance Technologies Inc
Data: 2026-01-02
$0.74
Price
-43.08%
Change
$14.28
52W High
$0.702
52W Low
Buy/Sell Forecast Trendline Why Moving Charts Options

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

Quick Stats

48.7

AI Score

HOLD

15.46

Volume Ratio

Next Earnings

7

+ve Days (30d)

20

-ve Days (30d)

PTIX Stock Summary

Last updated

PTIX is currently trading at $0.74, positioned below its 200-day moving average of $, suggesting bearish momentum. The stock has a 52-week range of $0.702 to $14.28.

Technical Analysis: The 50-day moving average stands at $, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads , suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is , which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates PTIX at 48.7/100 with a HOLD recommendation.

PTIX Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

PTIX Price vs Max Options Open Interest
PTIX Max Change In Options Open Interest

PTIX Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

PTIX Daily Out of Money Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

PTIX Daily In the Money Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

PTIX Most Active Options by Volume(near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track

Performance Technologies Inc is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

PTIX Moving Averages Analysis

PTIX (Performance Technologies Inc) Simple Moving Averages

Moving Averages are last updated

Days MA

PTIX Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 1.4 million
Earnings/Share ($) -13.13
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) 0
EPS Estimate Next Year ($) 0
WallStreet Target Price ($) 4
Most Recent Quarter